TPA 023
≥99%
- Product Code: 102994
CAS:
252977-51-8
| Molecular Weight: | 395.43 g./mol | Molecular Formula: | C₂₀H₂₂FN₇O |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
TPA 023 is primarily researched for its potential therapeutic applications in the field of neuroscience and psychiatry. It functions as a selective GABA_A receptor partial agonist, which makes it a promising candidate for treating anxiety disorders. Unlike traditional benzodiazepines, TPA 023 is designed to provide anxiolytic effects without the significant sedative or cognitive-impairing side effects, making it a safer option for long-term use. Additionally, it has been studied for its potential in managing insomnia and other stress-related conditions. Its unique pharmacological profile also suggests it could be useful in addressing symptoms of post-traumatic stress disorder (PTSD) and generalized anxiety disorder (GAD). Ongoing research continues to explore its efficacy and safety in clinical settings.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | €887.78 |
+
-
|
| 0.005 | 10-20 days | €1,762.26 |
+
-
|
TPA 023
TPA 023 is primarily researched for its potential therapeutic applications in the field of neuroscience and psychiatry. It functions as a selective GABA_A receptor partial agonist, which makes it a promising candidate for treating anxiety disorders. Unlike traditional benzodiazepines, TPA 023 is designed to provide anxiolytic effects without the significant sedative or cognitive-impairing side effects, making it a safer option for long-term use. Additionally, it has been studied for its potential in managing insomnia and other stress-related conditions. Its unique pharmacological profile also suggests it could be useful in addressing symptoms of post-traumatic stress disorder (PTSD) and generalized anxiety disorder (GAD). Ongoing research continues to explore its efficacy and safety in clinical settings.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
€0.00
€0.00
Total :